Facebook Icon Youtube Icon
Facebook Icon Youtube Icon
Facebook Icon Youtube Icon

Compare Be Healthy! Be Happy! zinc Immune Support Lozenges to common cold medicines

Compare Be Healthy! Be Happy! zinc Immune Support Lozenges to Emergen-C, Mucinex, and DayQuil cold remedies

 Products: Be Healthy! Be Happy! Emergen-C Super Mucinex-D DayQuil Severe
Active Ingredients See below See below See below See below
Proven to shorten the duration and severity of the common cold* [1],[2],[3],[4],[5],[6] Yes No No No
Decongestant, cough suppressant, analgesic No No Yes Yes
Ingredients found naturally in nature Yes Yes No – manufactured chemicals No – manufactured chemicals
Headache No Yes Yes Yes
Dizziness No No Yes Yes
Metallic taste Yes No No No
Nausea Yes Yes No Yes
Vomiting No No No Yes
Liver toxic No No No Yes
Diarrhea Yes No No Yes
Confusion No No No Yes
Seizures No No Yes No
Anxiety No No Yes Yes
Blurred vision No No No Yes
Irregular heart No No Yes No
Difficult urination No No No Yes
Confusion No No No Yes
Increased blood pressure No No Yes No
Labored breathing No No No Yes
Active Ingredients:
Be Healthy! Be Happy! Zinc acetate Zinc gluconate Selenium selenite
Mucinex-D Guaifenesin Pseudoephedrine
Emergen-C Super Vitamin C Vitamin B1, B2, B5 Vitamin B9, B12 Manganese
DayQuil Severe Acetaminophen Guaifenesin Dextromethorphan Phenylephrine

*This statement has not been evaluated by the FDA. This product is not intended to diagnose, prevent, cure or treat any disease.

Source (ingredients and side effects): Drugs.com @ www.drugs.com


[1] Hemilä, H., 2015. The effectiveness of high-dose zinc acetate lozenges on various common cold symptoms: a meta-analysis, BMC Family Practice, 16:24, pp. 1-11.

[2] Science, M., 2012. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials, CMAJ, 184(10), pp. E551-E561.

[3] Hemilä, H., 2011. Zinc lozenges may shorten the duration of colds: a systematic review. The Open Respiratory Medicine Journal, 5, pp. 51-58.

[4] Prasad, A., 2008. Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. The Journal of Infectious Diseases, 197, pp. 795-802.

[5] Prasad, A., 2000. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate, Annals of Internal Medicine, 133 (4), pp. 245-252.

[6] Petrus, E., 1998. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Current Therapeutic Research, 59 (9), pp. 594-607.